Knowledge Center

Article / Aug 01, 2014

Pharmaceutical Manufacturing and Supply-Chain Trends to 2020

Authors:
  • Guy Villax
Source:
Pharmaceutical Technology Europe, August 2014

A breach in the pharmaceutical supply chain is only the tip of the iceberg.
Innovators (Big Pharma and biotech companies) are today a minority player supplying only about 20% of the world’s medicines. At present, the vast majority of medicines are generic—the fruits of the best science of the 20th century can now be enjoyed for a few cents a pill.

Related links

Read article here

Also in the Knowledge Center

Related Content

Dry Powder Inhalation formulation development

Hovione has considerable inhalation experience that allows us to implement strategies including conventional carrier based, neat (drug-alone) or composite particle formulations.

Page
Read more

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

Enhanced process understanding

Ensuring enhanced understanding through state of the art methodologies and technologies.

Page
Read more